Pablo Corral Highlights CRIC Study: Aspirin, Lipoprotein(a), and Cardiorenal Outcomes in CKD
Pablo Corral, Past President of Argentine Lipid Society, has shared a post on Linkedin:
“Primary Prevention Aspirin, Lipoprotein(a), and Cardiorenal Outcomes in Chronic Kidney Disease
New data from the CRIC study
In CKD patients without clinical CVD, aspirin use was associated with 38% lower MI risk and 28% lower ESRD risk — but only when Lp(a) ≥50 mg/dL.
No significant benefit was seen when Lp(a) <50 mg/dL, and bleeding risk did not increase.”
Title: Primary Prevention Aspirin, Lipoprotein(a), and Cardiorenal Outcomes in Chronic Kidney Disease: Chronic Renal Insufficiency Cohort
Authors: Alexander C. Razavi, Jing Chen, Wei Yang, Daohang Sha, Omar Dzaye, Harpreet S. Bhatia, Sotirios Tsimikas, James P. Lash, Mayank Kansal, Hernan Rincon-Choles, Viola Vaccarino, Terry A. Jacobson, Matthew J. Budoff, Roger S. Blumenthal, Seamus P. Whelton, Laurence S. Sperling, Michael J. Blaha, Jiang H
Read the full article here.
Read more on Hemostasis Today.
-
Jan 12, 2026, 04:51Coronary Microvascular Dysfunction and HFpEF․ Prognostic Importance and Therapeutic Insights
-
Jan 12, 2026, 04:16Wolfgang Miesbach on VTE and Cancer: A 20-Year Signal That Can’t Be Ignored
-
Jan 12, 2026, 03:54Francine Freitas Fernandes on Transvaginal US for Pelvic Venous Disorders
-
Jan 12, 2026, 02:58Jara Garcia Ugaldebere Shares STORM-PE Results: Thrombectomy Plus Anticoagulation for Acute High-Risk PE
-
Jan 12, 2026, 02:54Discover the New Blood Project․ Enhanced Search, Browsing, and Learning Resources
-
Jan 12, 2026, 02:54Can Preoperative Iron Status Predict Severe Anemia After Bariatric Surgery?
-
Jan 12, 2026, 02:27Bryce Kerlin to Impact of Advanced Hemostasis/Thrombosis Fellowship Training at Haemophilia Publication
-
Jan 12, 2026, 02:21Martin Haluzík on Compariosn of Cardiovascular Outcomes Between Semaglutide and Dulaglutide Therapies
-
Jan 12, 2026, 01:55Frank Weinz on State-of-the-Art Thromboembolism Prophylaxis